StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
HCL.AX$0.17+3.03%
Fair $0.17+0.0%

HCL.AX

HighCom Limited

Industrials / Aerospace & DefenseASX

$0.17

+0.00 (+3.03%)

Fairly Valued+0.0%Fair Value $0.17Fund rank 29/100 · Data gapFallback financials|
SA 26/D
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $-460004.00 · quality 53.0/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -39.0%, below the 5% threshold
Thesis & Journal · HCL.AXLocal privado en este navegador · HighCom Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$24M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-39.0%

↓

Gross Margin

29.6%

↑

Debt/Equity

0.02

↓
52-Week Range$0
$0$1

TradingView lightweight chart

HCL.AX price, volumen y niveles de valoración

Último $0.170Periodo -97.4%
Fair value: $0.170

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

+17.1%

FCF CAGR

—

FCF margin

-1.0%

FCF / Net income

0.04x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $45.3M · net income $-12.0M · FCF $-460004.0

2021-FY → 2024-FY

Gross margin

29.6%+1.2% pts

Operating margin

-12.6%+2.4% pts

Net margin

-26.5%-12.4% pts

FCF margin

-1.0%+25.4% pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$45.3M$45.3M$89.4M$58.1M$28.2M
Net Income$-12.0M$-12.0M$6.1M$5.7M$-4.0M
EBITDA$-9.5M$-9.5M$10.8M$6.6M$-2.9M
EPS-0.12-0.120.060.06—
Gross Margin29.6%29.6%37.7%47.1%28.4%
Operating Margin-12.6%-12.6%10.8%8.6%-15.0%
Net Margin-26.5%-26.5%6.8%9.9%-14.1%
Balance Sheet
Debt/Equity0.020.020.040.040.09
Current Ratio2.152.15———
Cash Flow
Free Cash Flow$-460004.00$-460004.00$-28.0M$24.0M$-7.5M
Returns
ROE-39.0%-39.0%14.5%16.5%-18.6%
Valuation
P/E——6.256.83—
EV/EBITDA——3.020.69—
P/B0.560.560.901.131.51
Growth & Yield
Revenue Growth-49.3%-49.3%53.9%105.8%—
EPS Growth-295.7%-295.7%-4.8%——

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -5.6%

Total return

-5.6%

Start / end P/E

n/dx → n/dx

EPS bridge

0.06 → -0.12

Residual

-5.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-5.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.